Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Islet cell autoantigen 1, 69kDa pseudogene" designates a *pseudogene* (nonfunctional genomic DNA sequence resembling a gene) related to *ICA1*, which encodes the protein ICA69, a known islet autoantigen in type 1 diabetes. The pseudogene itself does not produce a functional protein and therefore is not a therapeutic target, nor does it possess direct biological function or disease association. It lacks the properties of typical drug targets like receptors, enzymes, or transporters[1]. In clinical and experimental literature, *ICA69* is discussed for its role in autoimmunity, particularly type 1 diabetes[3][7], but *the pseudogene* (as identified by ENSG00000260395) is not functionally involved. If your interest is in the protein with autoimmune relevance, search for *Islet cell autoantigen 1, 69kDa* (ICA1), not the pseudogene[1][3][7]. Notes on correctness and interpretation: - *Is this a therapeutic target?* No. The pseudogene has no known function or role as a drug target. - *Is something wrong with this target?* Yes. This is a pseudogene, not an active gene or target protein. If drug discovery or functional studies are intended, the proper target is ICA1 (Islet cell autoantigen 1, 69kDa), not its pseudogene. - *Aliases:* The names found in public databases may include LOC100420536, which strictly refers to the pseudogene. - *If searching for target biology, functional studies, or druggability, ICD69/ICA1 is the correct functional gene/protein.*
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Islet cell autoantigen 1, 69kDa pseudogene (null).